RxDoctor Payments Data

Shawn Anthony, MD

Sports Medicine · New York, NYNPI 1508187741

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,600 of the $65,215 with a category attached, or 83.7%. Miach Orthopaedics, Inc. accounts for 68.5% of it on its own, with 6 other manufacturers making up the rest. Among sports medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,215in general payments, 2019–2025

Across 69 payments — averaging $945.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Miach Orthopaedics, Inc.$45K
  • Smith+Nephew$17K
  • Arthrex$2K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Joint Restoration Foundation, Inc.$289
  • Trice Medical, Inc.$200
  • plus $93 from 1 others

What the payments were for

  • Consulting fees$54,60084%
  • Speaking & faculty fees$2000%
  • Travel & lodging$5,7509%
  • Food & beverage$3,0955%
  • Education$1,5692%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,215 in reported general payments places this provider in the 90th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York

Medicare billing

Part B allowed, 2024
$98,690
Medicare patients
266
Services billed
974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam23$45

Paid to pharmacies, not to this prescriber.

Other sports medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →